Plasmapheresis treatment in COVID-19-related autoimmune meningoencephalitis: Case series

Abstract

Severe SARS-CoV-2 (COVID-19) infection has the potential for a high mortality rate. In this paper, we report the results of plasmapheresis treatment in a series of severely ill patients with COVID-19-related autoimmune meningoencephalitis in the Intensive Care Unit (ICU).

Description

Keywords

Autoimmune, Encephalitis, COVID-19, Plasmapheresis

Citation

Collections

Endorsement

Review

Supplemented By

Referenced By